Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.10−0.11 (-9.09%)
Close on Nov 18, 2026Market cap $69.75MP/E –Yield –
Equillium shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Equillium's shares outstanding was 112M at Jun 30, 2026. For fiscal 2025 it was 57M, up 62.1% from the year before. The highest annual figure on record is 57M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57M | +62.1% |
| FY2024 | Dec 31, 2024 | 35M | +1.8% |
| FY2023 | Dec 31, 2023 | 35M | +3.0% |
| FY2022 | Dec 31, 2022 | 34M | +17.1% |
| FY2021 | Dec 31, 2021 | 29M | +41.5% |
| FY2020 | Dec 31, 2020 | 20M | +17.1% |
| FY2019 | Dec 31, 2019 | 17M | +42.6% |
| FY2018 | Dec 31, 2018 | 12M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 112M | +213.0% |
| Q1 FY2026 | Mar 31, 2026 | 96M | +170.5% |
| Q4 FY2025 | Dec 31, 2025 | 92M | +160.2% |
| Q3 FY2025 | Sep 30, 2025 | 65M | +84.4% |
| Q2 FY2025 | Jun 30, 2025 | 36M | -2.4% |
| Q1 FY2025 | Mar 31, 2025 | 36M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | 35M | +0.9% |
| Q3 FY2024 | Sep 30, 2024 | 35M | +1.6% |
| Q2 FY2024 | Jun 30, 2024 | 37M | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | 35M | +2.4% |
| Q4 FY2023 | Dec 31, 2023 | 35M | +2.3% |
| Q3 FY2023 | Sep 30, 2023 | 35M | +1.5% |
| Q2 FY2023 | Jun 30, 2023 | 34M | +0.5% |
| Q1 FY2023 | Mar 31, 2023 | 34M | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | 34M | +16.8% |
| Q3 FY2022 | Sep 30, 2022 | 34M | +16.9% |
| Q2 FY2022 | Jun 30, 2022 | 34M | +17.9% |
| Q1 FY2022 | Mar 31, 2022 | 32M | +16.6% |
| Q4 FY2021 | Dec 31, 2021 | 29M | +18.8% |
| Q3 FY2021 | Sep 30, 2021 | 29M | +37.5% |
| Q2 FY2021 | Jun 30, 2021 | 29M | +64.3% |
| Q1 FY2021 | Mar 31, 2021 | 27M | +55.6% |
| Q4 FY2020 | Dec 31, 2020 | 25M | +42.5% |
| Q3 FY2020 | Sep 30, 2020 | 21M | +23.0% |
| Q2 FY2020 | Jun 30, 2020 | 18M | +1.8% |
| Q1 FY2020 | Mar 31, 2020 | 18M | +1.1% |
| Q4 FY2019 | Dec 31, 2019 | 17M | +6.9% |
| Q3 FY2019 | Sep 30, 2019 | 17M | +56.8% |
| Q2 FY2019 | Jun 30, 2019 | 17M | +62.2% |
| Q1 FY2019 | Mar 31, 2019 | 17M | +62.3% |
| Q4 FY2018 | Dec 31, 2018 | 16M | +51.8% |
| Q3 FY2018 | Sep 30, 2018 | 11M | – |
| Q2 FY2018 | Jun 30, 2018 | 11M | – |
| Q1 FY2018 | Mar 31, 2018 | 11M | – |
| Q3 FY2017 | Sep 30, 2017 | 11M | – |
See a number that looks wrong?